Search Within

Hematology-Oncology Fellows

  1. "The Lancet Haematology"
Formats
  1. Journal Article (3)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. GME, Medicine (4)
  4. Graduate Medical Education (4)
  5. Hematologic Malignancies, Division of (4)
  6. Adult Leukemia (3)

More Groups

People
  1. Ahmet Dogan (2)
  2. Eytan Stein (2)
  3. Martin Tallman (2)
  4. Mikhail Roshal (2)
  5. Omar Abdel-Wahab (2)
  6. Raajit Rampal (2)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (2)
Publications
  1. The Lancet Haematology (5)
Publishers
  1. Elsevier Science, Inc. (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standardising acute myeloid leukaemia classification systems: A perspective from a panel of international experts
    Review

    Shallis, R. M.; Daver, N.; Altman, J. K.; Komrokji, R. S.; Pollyea, D. A.; Badar, T.; Bewersdorf, J. P.; Bhatt, V. R.; de Botton, S.; de la Fuente Burguera, A.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: Recommendations from a panel of international experts
    Editorial

    Zeidan, A. M.; Boddu, P. C.; Patnaik, M. M.; Bewersdorf, J. P.; Stahl, M.; Rampal, R. K.; Shallis, R. M.; Steensma, D. P.; Savona, M. R.; Sekeres, M. A.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: A single-centre, single-arm, phase 2 trial
    Journal Article

    Taylor, J.; Mi, X.; Penson, A. V.; Paffenholz, S. V.; Alvarez, K.; Sigler, A.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save